OA resources

Author(s):

RheumatologyNetwork Staff

Arthritis Foundation

Fibromyalgia Network

Lupus Foundation of America

National Fibromyalgia Association

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Osteoporosis Foundation

United States Bone and Joint Decade

World Health Organization Women's Health Page

Related Videos
Linda Gillam, MD, MPH | Credit: Atlantic Health System
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Linda Gillam, MD, MPH | Credit: Atlantic Health System
Jonathan Meyer, MD: Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride
Chelsie Monroe: Challenges Clinicians Should Consider When Prescribing Muscarinic Modulators for Schizophrenia
Allysa Saggese, NP | Credit: Weill Cornell Medicine
Zobair Younossi, MD, MPH | Credit: American College of Gastroenterology
Related Content
Philip J. Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
October 14th 2024

Guselkumab Yields Durable Improvements in Psoriatic Arthritis

Victoria Johnson
Taher Modarressi, MD | Credit: X.com
October 3rd 2024

Don't Miss a Beat: Putting Evidence-Based Cardiometabolic Therapies into Practice, with Taher Modarressi, MD

Muthiah Vaduganathan, MD, MPH Stephen Greene, MD
Antonio Anzueto, MD | Credit: UT Health San Antonio
October 14th 2024

The Potential Role of Dupilumab in COPD Management, with Antonio Anzueto, MD

Patrick Campbell
MEDCast Podcast logo
October 1st 2024

Exploring Oral Systemic Therapies for Plaque Psoriasis: Efficacy, Safety, and Clinical Considerations

Lauren Miller, MPAS, PA-C Jayme M Heim, MSN, FNP-BC Kirk Gautier, PA-C
Online Tool Developed to Improve Diagnostic Skills of Non-Dermatologists for Psoriasis
October 14th 2024

Online Tool Developed to Improve Diagnostic Skills of Non-Dermatologists for Psoriasis

Tim Smith
FDA Approves Ustekinumab (STELARA) Biosimilar for Chronic Inflammatory Diseases
October 14th 2024

FDA Approves Ustekinumab (STELARA) Biosimilar for Chronic Inflammatory Diseases

Kevin Kunzmann
© 2024 MJH Life Sciences

All rights reserved.